Lv2
160 积分 2024-01-09 加入
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
16天前
已完结
Overcoming therapy resistance in EGFR-mutant lung cancer
16天前
已完结
Stabilin-1+ lipid-associated macrophages promote lung adenocarcinoma liver metastasis and osimertinib resistance through impairing macrophage phagocytosis via SIRPα-CD47 axis
22天前
已完结
Emerging paradigms in the study of brain metastases
1个月前
已完结
Current landscape and recent developments of PI3K/AKT/mTOR targeted inhibitors for breast carcinoma
1个月前
已完结
糖尿病合并肺炎诊治路径中国专家共识
2个月前
已完结
Targeted delivery of nano-radiosensitizers for tumor radiotherapy
5个月前
已完结
Assessing dosimetric advancements in spatially fractionated radiotherapy: From grids to lattices
5个月前
已完结
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patients
6个月前
已完结
Circulating Tumour DNA in Patients With EGFR‐Mutated Non‐Small‐Cell Lung Cancer and Early Disease Progression After First‐Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study
6个月前
已关闭
皖公网安备34019202002308
